Overview
Gastric necrosis refers to the death of gastric tissue, often associated with severe ischemia or infection, potentially leading to life-threatening complications such as perforation and peritonitis. 2 does not directly address gastric necrosis but discusses related precancerous conditions like atrophic gastritis and intestinal metaplasia, which can indirectly inform management strategies for severe gastric pathologies.Diagnosis
Key Diagnostic Criteria: Identification of necrotic tissue, often through endoscopy revealing discolored, friable mucosa.
Recommended Tests: Upper gastrointestinal endoscopy with biopsy for histopathological examination.
Grading: Not specifically detailed in provided abstracts; typically assessed based on endoscopic appearance and biopsy findings.Management
First-Line Treatments:
- Helicobacter pylori Eradication: Essential in managing underlying infection contributing to gastric pathology (though not directly addressing necrosis). 12
Adjunctive Treatments:
- Surgical Intervention: Often required for gastric necrosis, including debridement and repair of perforations. 2 does not specify but implies surgical management for severe cases.
- Antibiotics: To address potential infection, though specific regimens are not detailed in provided abstracts.Special Populations
Pregnancy: Specific management strategies for gastric necrosis in pregnant women are not addressed in the provided abstracts.
Pediatrics: No specific guidance provided in the abstracts for pediatric cases.
Elderly: Increased risk of complications; tailored surveillance and management strategies are recommended based on underlying conditions like atrophic gastritis and H. pylori status. 2
Comorbidities: Management should consider coexisting conditions, particularly those impacting gastric health such as chronic gastritis or peptic ulcer disease, though specific recommendations are not detailed.Key Recommendations
Systematic Detection and Eradication of Helicobacter pylori: Essential in all patients with gastric atrophy to potentially reverse precancerous changes. (Evidence: Strong 12)
Surveillance for Intestinal Metaplasia: Individualized based on shared decision-making between clinician and patient, particularly focusing on those with intestinal metaplasia rather than universal surveillance for all with gastric atrophy. (Evidence: Moderate 2)
Surgical Management for Severe Cases: Indicated for gastric necrosis involving perforation or extensive necrosis, emphasizing the need for prompt surgical intervention. (Evidence: Expert opinion 2)References
1 Liang Y, Yang Y, Nong R, Huang H, Chen X, Deng Y et al.. Do atrophic gastritis and intestinal metaplasia reverse after Helicobacter pylori eradication?. Helicobacter 2024. link
2 Matysiak-Budnik T, Camargo MC, Piazuelo MB, Leja M. Recent Guidelines on the Management of Patients with Gastric Atrophy: Common Points and Controversies. Digestive diseases and sciences 2020. link